Equity Overview
Price & Market Data
Price: $210.4
Daily Change: +$7.89 / 3.75%
Daily Range: $205.5 - $210.4
Market Cap: $14,252,344,320
Daily Volume: 572
Performance Metrics
1 Week: -2.67%
1 Month: -14.58%
3 Months: -28.59%
6 Months: -34.50%
1 Year: -20.99%
YTD: -28.77%
Company Details
Employees: 5400
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.